glp-1 digestive blockage lawsuit in west virginia The FDA sent a warning letter to the maker of Ozempic and Wegovy over unreported potential side effects. Here's what to know Virginia legislators weigh the cost

Patients receive unclear instructions about measuring doses, use the wrong syringe type, or misunderstand the differences between formulation strengths

It is not medical advice, and the material is not intended for human consumption

Image Credit: CI Photos / Shutterstock In a recent study published in the journal Cell Metabolism , a group of researchers evaluated whether glucagon-like peptide-1 receptor (GLP-1R) agonism counteracts aging across organs in a largely weight-neutral context, defined its hypothalamic dependence, and benchmarked effects against mammalian target of rapamycin (mTOR) inhibition

the same 25-unit draw of 5 mg/ml tirzepatide is 1.25 mg

Does Stacking Increase Risk Compared to Single-Peptide Therapy